牛牛AI助理已提取核心訊息
Matthew Scott Harris, Chief Medical Officer of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1 and 2, 2024. Harris exercised options to acquire a total of 13,941 shares of common stock at no cost. Concurrently, he disposed of 4,133 shares to cover exercise prices or tax liabilities, with the sales priced between $9.32 and $9.88 per share, resulting in a total market value of $39,528.12. Following these transactions, Harris holds a total of 53,633 Altimmune shares directly.
Matthew Scott Harris, Chief Medical Officer of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1 and 2, 2024. Harris exercised options to acquire a total of 13,941 shares of common stock at no cost. Concurrently, he disposed of 4,133 shares to cover exercise prices or tax liabilities, with the sales priced between $9.32 and $9.88 per share, resulting in a total market value of $39,528.12. Following these transactions, Harris holds a total of 53,633 Altimmune shares directly.
Altimmune, Inc. [ALT] 首席醫療官馬修·斯科特·哈里斯於2024年2月1日和2日完成了一系列股票交易。哈里斯行使期權免費收購了總共13,941股普通股。同時，他出售了4,133股股票以支付行使價或納稅義務，銷售價格在每股9.32美元至9.88美元之間，總市值爲39,528.12美元。在這些交易之後，哈里斯直接持有總計53,633股Altimmune股票。
Altimmune, Inc. [ALT] 首席醫療官馬修·斯科特·哈里斯於2024年2月1日和2日完成了一系列股票交易。哈里斯行使期權免費收購了總共13,941股普通股。同時，他出售了4,133股股票以支付行使價或納稅義務，銷售價格在每股9.32美元至9.88美元之間，總市值爲39,528.12美元。在這些交易之後，哈里斯直接持有總計53,633股Altimmune股票。
有用
沒用